Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 2,000 | 2,000 | 3,000 | 6,000 | 0.00 | -- |
| Operating Revenue | 2,000 | 2,000 | 3,000 | 6,000 | 0.00 | -- |
| Selling General And Administration | 123,000 | 169,000 | 125,000 | 123,000 | 189,000 | -- |
| General And Administrative Expense | 123,000 | 169,000 | 125,000 | 123,000 | 189,000 | -- |
| Operating Expense | 123,000 | 169,000 | 125,000 | 123,000 | 189,000 | -- |
| Operating Income | -121,000 | -167,000 | -122,000 | -117,000 | -189,000 | -- |
| EBIT | 83,000 | 0.00 | 20,000 | 755,000 | 52,000 | -- |
| Interest Expense | 52,000 | 52,000 | 52,000 | -- | 124,000 | -- |
| Interest Expense Non Operating | 52,000 | 52,000 | 52,000 | -- | 124,000 | -- |
| Interest Income | 198,000 | 195,000 | 195,000 | 582,000 | 0.00 | -- |
| Interest Income Non Operating | 198,000 | 195,000 | 195,000 | 582,000 | 0.00 | -- |
| Net Interest Income | 146,000 | 143,000 | 143,000 | 383,000 | -124,000 | -- |
| Other Income Expense | 6,000 | -28,000 | -53,000 | -317,000 | 241,000 | -- |
| Other Non Operating Income Expenses | -- | -- | -- | -219,000 | 248,000 | -- |
| Gain On Sale Of Security | 6,000 | -28,000 | -53,000 | -98,000 | -7,000 | -- |
| Pretax Income | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Net Income From Continuing Operation Net Minority Interest | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Net Income Including Noncontrolling Interests | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Net Income Common Stockholders | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Net Income | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| EBITDA | 83,000 | 0.00 | 20,000 | 755,000 | 52,000 | -- |
| Normalized EBITDA | 77,000 | 28,000 | 73,000 | 853,000 | 59,000 | -- |
| Basic EPS | 0.03 | -0.05 | -0.03 | -- | -0.07 | 0.32 |
| Diluted EPS | 0.03 | -0.05 | -0.03 | -- | -0.07 | 0.32 |
| Basic Average Shares | 1.1M | 1.1M | 1.1M | -- | 1.1M | 1.1M |
| Diluted Average Shares | 1.1M | 1.1M | 1.1M | -- | 1.1M | 1.1M |
| Total Unusual Items | 6,000 | -28,000 | -53,000 | -98,000 | -7,000 | -- |
| Total Unusual Items Excluding Goodwill | 6,000 | -28,000 | -53,000 | -98,000 | -7,000 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | 25,000 | -24,000 | 21,000 | 47,000 | -65,000 | -- |
| Diluted NI Availto Com Stockholders | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Net Income Continuous Operations | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Net Non Operating Interest Income Expense | 146,000 | 143,000 | 143,000 | 383,000 | -124,000 | -- |
| Other Gand A | 61,000 | 107,000 | 63,000 | -128,000 | 128,000 | -- |
| Salaries And Wages | 62,000 | 62,000 | 62,000 | 251,000 | 61,000 | -- |
| Total Expenses | 123,000 | 169,000 | 125,000 | 123,000 | 189,000 | -- |
| Total Other Finance Cost | -- | -- | -- | 1,000 | -- | 1,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 68,000 | 10,000 | 124,000 | 31,000 | 101,000 | -- |
| Cash Cash Equivalents And Short Term Investments | 68,000 | 10,000 | 124,000 | 31,000 | 101,000 | -- |
| Accounts Receivable | -- | -- | -- | -- | 300,000 | 300,000 |
| Receivables | 897,000 | 796,000 | 796,000 | 696,000 | 300,000 | -- |
| Inventory | -- | -- | -- | 0.00 | -- | -- |
| Current Assets | 965,000 | 806,000 | 920,000 | 727,000 | 401,000 | -- |
| Net PPE | -- | -- | -- | 0.00 | -- | -- |
| Goodwill And Other Intangible Assets | 398,000 | 398,000 | 395,000 | 393,000 | 380,000 | -- |
| Other Intangible Assets | 398,000 | 398,000 | 395,000 | 393,000 | -- | -- |
| Other Non Current Assets | -- | -- | -- | -- | 15.4M | 15.6M |
| Total Non Current Assets | 11.1M | 11.3M | 11.1M | 11.4M | 15.8M | -- |
| Total Assets | 12.0M | 12.1M | 12.0M | 12.1M | 16.2M | -- |
| Current Debt | 3.9M | 3.9M | 3.8M | 3.8M | 3.7M | -- |
| Current Debt And Capital Lease Obligation | 3.9M | 3.9M | 3.8M | 3.8M | 3.7M | -- |
| Accounts Payable | 1.6M | 1.8M | 1.7M | 1.7M | 1.4M | -- |
| Payables | 1.7M | 1.8M | 1.7M | 1.7M | 1.5M | -- |
| Payables And Accrued Expenses | 1.7M | 1.8M | 1.7M | 1.7M | 1.5M | -- |
| Other Current Liabilities | -- | -- | -- | -- | 5,000 | 5,000 |
| Current Liabilities | 5.6M | 5.7M | 5.6M | 5.5M | 5.2M | -- |
| Other Non Current Liabilities | -- | -- | -- | 1,000 | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 1,000 | 0.00 | 1,000 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 5.6M | 5.7M | 5.6M | 5.5M | 5.2M | -- |
| Common Stock | 230.8M | 230.8M | 232.5M | 235.7M | 239.0M | -- |
| Capital Stock | 230.8M | 230.8M | 232.5M | 235.7M | 239.0M | -- |
| Additional Paid In Capital | 18.6M | 18.6M | 18.6M | 18.6M | 18.6M | -- |
| Retained Earnings | -216.0M | -216.1M | -217.6M | -220.8M | -219.7M | -- |
| Gains Losses Not Affecting Retained Earnings | -26.9M | -26.9M | -26.9M | -26.9M | -26.9M | -- |
| Other Equity Adjustments | -26.9M | -26.9M | -26.9M | -26.9M | -26.9M | -- |
| Common Stock Equity | 6.5M | 6.4M | 6.5M | 6.6M | 10.9M | -- |
| Stockholders Equity | 6.5M | 6.4M | 6.5M | 6.6M | 10.9M | -- |
| Total Equity Gross Minority Interest | 6.5M | 6.4M | 6.5M | 6.6M | 10.9M | -- |
| Total Capitalization | 6.5M | 6.4M | 6.5M | 6.6M | 10.9M | -- |
| Net Tangible Assets | 6.1M | 6.0M | 6.1M | 6.2M | 10.6M | -- |
| Tangible Book Value | 6.1M | 6.0M | 6.1M | 6.2M | 10.6M | -- |
| Working Capital | -4.6M | -4.9M | -4.6M | -4.8M | -4.8M | -- |
| Invested Capital | 10.4M | 10.3M | 10.3M | 10.3M | 14.7M | -- |
| Total Debt | 3.9M | 3.9M | 3.8M | 3.8M | 3.7M | -- |
| Net Debt | 3.9M | 3.9M | 3.7M | 3.8M | 3.6M | -- |
| Share Issued | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | -- |
| Ordinary Shares Number | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | -- |
| Non Current Accounts Receivable | 10.7M | 10.9M | 10.7M | 11.0M | -- | -- |
| Other Current Borrowings | 3.9M | 3.9M | 3.8M | 3.8M | 3.7M | -- |
| Other Receivables | 897,000 | 796,000 | 796,000 | 696,000 | -- | -- |
| Total Tax Payable | 21,000 | 22,000 | 21,000 | 21,000 | 22,000 | -- |
| Treasury Shares Number | -- | -- | -- | 15,300 | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -281,000 | -100,000 | -197,000 | -318,000 | 37,000 | -- |
| Cash Flow From Continuing Operating Activities | -281,000 | -100,000 | -197,000 | -318,000 | 37,000 | -- |
| Stock Based Compensation | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Change In Working Capital | -163,000 | 98,000 | -21,000 | 503,000 | 102,000 | -- |
| Change In Other Working Capital | -163,000 | 98,000 | -21,000 | -- | -163,000 | 65,000 |
| Change In Other Current Assets | 0.00 | 0.00 | 0.00 | -- | 265,000 | -473,000 |
| Change In Other Current Liabilities | 0.00 | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Other Non Cash Items | 52,000 | -143,000 | 52,000 | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -186,000 | -131,000 |
| Purchase Of PPE | -- | -- | -- | -- | -- | 0.00 |
| Net PPE Purchase And Sale | -- | -- | -- | -- | 0.00 | 0.00 |
| Investing Cash Flow | 339,000 | 0.00 | 321,000 | 408,000 | -187,000 | -- |
| Cash Flow From Continuing Investing Activities | 339,000 | 0.00 | 321,000 | 408,000 | -187,000 | -- |
| Issuance Of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 200,000 | -- |
| Net Issuance Payments Of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 200,000 | -- |
| Repurchase Of Capital Stock | 0.00 | -14,000 | -31,000 | -- | 0.00 | 0.00 |
| Net Common Stock Issuance | 0.00 | -14,000 | -31,000 | -- | 0.00 | 0.00 |
| Common Stock Payments | 0.00 | -14,000 | -31,000 | -- | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | -14,000 | -31,000 | -159,000 | 251,000 | -- |
| Cash Flow From Continuing Financing Activities | 0.00 | -14,000 | -31,000 | -159,000 | 251,000 | -- |
| Changes In Cash | 60,000 | -114,000 | 93,000 | -70,000 | 101,000 | -- |
| Beginning Cash Position | 10,000 | 124,000 | 31,000 | 101,000 | 0.00 | -- |
| End Cash Position | 70,000 | 10,000 | 124,000 | 31,000 | 101,000 | -- |
| Free Cash Flow | -281,000 | -100,000 | -197,000 | 59,000 | -149,000 | -- |
| Income Tax Paid Supplemental Data | -- | 0.00 | -- | -- | 0.00 | 0.00 |
| Interest Paid Supplemental Data | -- | 52,000 | -- | -- | 51,000 | 49,000 |
| Amortization Of Securities | -199,000 | -- | -194,000 | -- | 0.00 | -- |
| Gain Loss On Investment Securities | -2,000 | -- | -2,000 | -- | -- | -- |
| Gain Loss On Sale Of PPE | -- | -3,000 | -- | -- | -- | 0.00 |
| Net Foreign Currency Exchange Gain Loss | 0.00 | 0.00 | 0.00 | -- | 7,000 | -4,000 |
| Net Income From Continuing Operations | 31,000 | -52,000 | -32,000 | -51,000 | -72,000 | -- |
| Net Intangibles Purchase And Sale | 0.00 | 0.00 | 0.00 | -- | -186,000 | -131,000 |
| Net Other Financing Charges | -- | -- | -- | -- | 51,000 | 48,000 |
| Net Other Investing Changes | 339,000 | -- | 321,000 | 31,000 | -1,000 | -2,000 |
| Net Short Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 200,000 | -- |
| Operating Gains Losses | -2,000 | -3,000 | -2,000 | -4,000 | 7,000 | -- |
| Sale Of PPE | -- | -- | -- | -- | 0.00 | -- |
| Short Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 200,000 | -- |